康缘药业(600557) - 2016 Q1 - 季度财报

Financial Performance - Operating revenue for the first quarter reached CNY 698,297,664.70, a 6.12% increase year-on-year[5] - Net profit attributable to shareholders was CNY 82,365,842.77, reflecting a 0.92% increase compared to the same period last year[5] - The company reported a basic earnings per share of CNY 0.16, unchanged from the previous year[5] - Total operating revenue for Q1 2016 was CNY 698,297,664.70, an increase of 6.1% compared to CNY 658,029,406.40 in Q1 2015[33] - Net profit for Q1 2016 reached CNY 82,922,482.92, representing a growth of 1.3% from CNY 81,898,748.57 in Q1 2015[33] - The net profit attributable to shareholders of the parent company was CNY 82,365,842.77, an increase from CNY 81,617,680.53 in the same period last year[34] - The total comprehensive income for Q1 2016 was CNY 82,920,773.60, compared to CNY 81,906,189.55 in Q1 2015[34] Assets and Liabilities - Total assets increased by 1.20% to CNY 4,355,957,768.47 compared to the end of the previous year[5] - Accounts receivable decreased by 32.65% to CNY 477,750,469.17 due to a reduction in outstanding bills[11] - Other current assets decreased by 57.16% to CNY 4,650,000.00, mainly due to a reduction in financial products[11] - The company's total liabilities decreased significantly, with long-term borrowings dropping to CNY 0 from CNY 45 million, a 100.00% reduction[25] - Total liabilities decreased to CNY 1,402,290,088.18 from CNY 1,433,756,111.49, a decline of about 2.2%[27] - Owner's equity increased to CNY 2,953,667,680.29 from CNY 2,870,746,906.69, representing a growth of approximately 2.9%[27] Cash Flow - Cash flow from operating activities showed a slight decrease of 0.03% to CNY 137,589,323.00[5] - The net cash flow from operating activities was CNY 137,589,323.00, showing a slight decrease of 0.04% from CNY 137,637,241.14 in Q1 2015[39] - The company experienced a net cash outflow from investing activities of CNY 177,737,428.40, compared to a net outflow of CNY 147,629,474.07 in the previous year[40] - The net cash flow from financing activities was CNY 28,045,311.19, recovering from a net outflow of CNY 201,862,218.88 in the same quarter last year[40] - The ending balance of cash and cash equivalents decreased to CNY 209,612,288.40 from CNY 341,697,499.01, reflecting a decline of 38.6% year-over-year[40] Shareholder Information - The number of shareholders reached 28,343, with Jiangsu Kangyuan Group holding 27.48% of shares[8] - The net profit attributable to minority shareholders increased to CNY 556,640.15, up 98.04% from CNY 281,068.04[14] Other Financial Metrics - The weighted average return on net assets decreased by 0.32 percentage points to 2.89%[5] - Cash and cash equivalents decreased to CNY 209.61 million from CNY 221.72 million, a decline of 5.00%[25] - Accounts receivable increased to CNY 1.13 billion from CNY 956.31 million, representing a growth of 18.00%[25] - The construction in progress rose significantly to CNY 135.81 million, up 47.10% from CNY 92.33 million[25] - Other non-current assets surged to CNY 96.98 million, a 199.44% increase compared to CNY 32.39 million[25] - Cash inflows from financing activities totaled CNY 686,000,000.00, a substantial increase from CNY 102,474,286.67 in Q1 2015[40] - The cash inflow from sales of goods and services for the parent company was CNY 773,207,471.07, up from CNY 590,468,590.06, marking a growth of 31.0%[42]